Breaking News Instant updates and real-time market news.

GPS

Gap

$24.90

-1.11 (-4.27%)

, TIF

Tiffany

$87.87

-1.98 (-2.20%)

10:17
01/22/19
01/22
10:17
01/22/19
10:17

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Gap (GPS) downgraded to Sell from Neutral at Goldman Sachs while Tiffany (TIF) was downgraded to Neutral from Buy. 2. U.S. Steel (X) downgraded to Hold from Buy at Jefferies with analyst Seth Rosenfeld saying "poor" Q4 earnings and Q1 guides will begin to reflect the extent of recent steel margin weakness. 3. Fortinet (FTNT) downgraded to Market Perform from Outperform at BMO Capital with analyst Keith Bachman saying he is not bearish on the stock, expecting the firewall market to remain healthy for several years given the changing throughput requirements, but sees the rating change as reflective of its more balanced risk-reward. 4. Crispr Therapeutics (CRSP) downgraded to Sell from Neutral at Citi with analyst Yigal Nochomovitz saying Crispr's near-term valuation driver and lead program in related blood disorders "substantially lags" more advanced competitors. 5. AMC Entertainment (AMC) downgraded to Neutral from Buy at B. Riley FBR with analyst Eric Wold saying the ramp of the company's subscription service Stubs A-List clouds its EBITDA visibility. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

GPS

Gap

$24.90

-1.11 (-4.27%)

TIF

Tiffany

$87.87

-1.98 (-2.20%)

X

U.S. Steel

$20.66

-0.845 (-3.93%)

FTNT

Fortinet

$69.16

-1.34 (-1.90%)

CRSP

Crispr Therapeutics

$32.07

-5.145 (-13.83%)

AMC

AMC Entertainment

$13.98

-0.49 (-3.39%)

  • 22

    Jan

  • 24

    Jan

  • 31

    Jan

  • 06

    Feb

  • 25

    Feb

  • 03

    Mar

GPS Gap
$24.90

-1.11 (-4.27%)

01/22/19
GSCO
01/22/19
DOWNGRADE
Target $23
GSCO
Sell
Goldman downgrades Gap to Sell on deteriorating brand momentum
Goldman Sachs analyst Alexandra Walvis downgraded Gap to Sell from Neutral and lowered her price target for the shares to $23 from $27. Fundamentals for Gap's specialty brands have been weak for some time and a more aggressive portfolio rationalization at the Gap brand "will prove to be insufficient to reinvigorate the business," Walvis tells investors in a research note. The analyst also believes a "tougher than anticipated" holiday season can lead to disappointing results for Gap's value-based portfolio, outlet and Old Navy. Deteriorating brand momentum and elevated promotionality compound continued mall-based retailing pressures, says Walvis. She sees 12% downside in Gap shares versus 17% average upside for her Apparel & Accessories coverage.
01/11/19
01/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Asset managers BlackRock (BLK), Eaton Vance (EV), Ivesco (IVZ), Affiliated Managers (AMG) and Legg Mason (LM) downgraded to Hold from Buy at Deutsche Bank, with analyst Brian Bedell saying their fundamentals are "unlikely to improve anytime soon." The analyst believes "investor neglect" toward the stocks should continue on fears of a market downturn, as well as due to poor fundamentals from product outflows and pressure on fee rates and operating margins. 2. Starbucks (SBUX) downgraded to Neutral from Buy at Goldman Sachs by analyst Karen Holthouse, saying she remains "reasonably confident" that Starbucks' initiatives to drive digital engagement can lead to a "more stable" 3%-4% comp trajectory in the U.S. over the next few years. However, its valuation has "rapidly re-rated" to reflect this, and gift cards and digital trends could be points of caution in fiscal Q1. The analyst also downgraded Yum! Brands (YUM) to Sell from Neutral. 3. Gap (GPS) downgraded to Underweight from Overweight at Barclays, with analyst Chethan Mallela saying he believes "challenging" traffic trends and "difficult" comparisons cloud visibility into the company's sales growth momentum. Further, the analyst believes the company's cost pressures will be larger than investors anticipate and pose risk to consensus estimates. 4. WW (WTW) downgraded to Neutral from Overweight at JPMorgan by analyst Christina Brathwaite, saying early in the year channel checks point to a weak start to 2019 for the company. The checks suggest traffic to WW''s website and engagement on its mobile app are down double-digit percentages year-over-year, the analyst added. 5. Hanesbrands (HBI) downgraded to Hold from Buy at Deutsche Bank, with analyst Tiffany Kanaga citing a deep dive of the company's international business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/19
FBCO
01/16/19
NO CHANGE
Target $50
FBCO
Neutral
Nordstrom price target lowered to $50 from $55 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Nordstrom (JWN) to $50 from $55 on weak full-price holiday adding to already clearance filled January. With Nordstrom adding to industry markdown issues, the analyst sees negative reads for J.C. Penney (JCP), Kohl's (KSS), Gap (GPS), but positive for Burlington Stores (BURL), Ross Stores (ROST), and TJX (TJX). Binetti reiterates a Neutral rating on Nordstrom shares.
01/22/19
GSCO
01/22/19
DOWNGRADE
Target $23
GSCO
Sell
Gap downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded Gap to Sell and lowered her price target for the shares to $23 from $27.
TIF Tiffany
$87.87

-1.98 (-2.20%)

01/04/19
SBSH
01/04/19
NO CHANGE
Target $125
SBSH
Buy
Tiffany shares already price in 'significant pessimism,' says Citi
Citi analyst Paul Lejuez lowered his price target for Tiffany to $125 from $140 and his 2019 earnings per share estimate to $5.18 from $5.50. Global macro concerns and pressure from Chinese tourism will likely continue into fiscal 2019, Lejuez tells investors in a research note titled "Some Near Term Uncertainty; Reduce TP, but Still a Lot to Like." The analyst believes it makes sense to be more cautious on Tiffany's fiscal 2019, but he thinks "significant pessimism" is already priced in with the stock down 30% since early November. The analyst says that despite a less certain macro backdrop near term, he remains optimistic longer term. Lejuez keeps a Buy rating on Tiffany.
01/22/19
NOMU
01/22/19
NO CHANGE
Target $108
NOMU
Buy
Tiffany price target lowered to $108 from $125 at Nomura Instinet
Nomura Instinet analyst Simeon Siegel lowered his price target for Tiffany to $108 after the company's holiday sales release and fiscal earnings guidance missed estimates. However, with the outlook "above fears," the shares traded higher, adds the analyst. He expects near-term pressures to persist with optimism towards the second half of 2019 and keeps a Buy rating on Tiffany.
01/22/19
GSCO
01/22/19
DOWNGRADE
Target $104
GSCO
Neutral
Tiffany downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded Tiffany to Neutral and lowered her price target for the shares to $104 from $136. The analyst sees increasing evidence of a "toughening macro environment" for luxury goods demand. Headwinds for high-end consumer and tourist spending at Tiffany will offset the company's continued progress on new management initiatives in the near term, Walvis tells investors in a research note. The analyst believes slowing sales growth will drive more limited operating leverage and earnings growth going forward for Tiffany.
01/18/19
LOOP
01/18/19
NO CHANGE
Target $100
LOOP
Buy
Tiffany price target cut to $100 from $110 at Loop Capital
Loop Capital analyst Laura Champine maintained a Buy rating on Tiffany & Co but lowered her price target to $100 after updating her model for a reduction in sales driven by market volatility and lower sales to Chinese tourists. The stock is attractive, she tells investors in a research note, given her longer-term expectations for top- and bottom-line growth and trades at 17.5x her F2019 EPS estimate and 10x F2019 EV/EBITDA.
X U.S. Steel
$20.66

-0.845 (-3.93%)

01/18/19
LBOW
01/18/19
DOWNGRADE
LBOW
Neutral
U.S. Steel downgraded to Neutral from Buy at Longbow
Longbow analyst Christopher Olin downgraded U.S. Steel to Neutral. The analyst sees risk in the company's tubular segment.
01/18/19
LBOW
01/18/19
DOWNGRADE
LBOW
Neutral
Longbow downgrades U.S. Steel to Neutral on tubular segment risk
As previously reported, Longbow analyst Christopher Olin downgraded U.S. Steel to Neutral from Buy citing what he called "disappointing feedback" from a quarterly oil country tubular goods, or OCTG, survey. Contacts reported the first negative volume comp since the fourth quarter of 2016 and decelerating demand is evident throughout the energy channels, Olin tells investors. Meanwhile, increasing supply, from both foreign and domestic suppliers, is resulting in lower price and volume estimates, he added.
01/22/19
JEFF
01/22/19
DOWNGRADE
Target $24
JEFF
Hold
U.S. Steel downgraded to Hold from Buy at Jefferies
Jefferies analyst Seth Rosenfeld downgraded U.S. Steel to Hold and lowered his price target for the shares to $24 from $38.
01/22/19
JEFF
01/22/19
DOWNGRADE
Target $24
JEFF
Hold
Jefferies downgrades U.S. Steel to Hold on guidance risk
Jefferies analyst Seth Rosenfeld downgraded U.S. Steel to Hold from Buy and lowered his price target for the shares to $24 from $38. "Poor" Q4 earnings and Q1 guides will begin to reflect the extent of recent steel margin weakness, Rosenfeld tells investors in a research note. The analyst, while remaining "constructive" on the broader Steel sector, downgraded U.S. Steel to reflect guidance risk and "increasingly challenged" long-term prospects. With both U.S. and European flat steel margins drifting lower, drivers for a "meaningful recovery" at the company are "hard to identify," says the analyst. As such, he believes U.S. Steel's 2019 EBITDA guidance risks disappointing consensus expectations. Rosenfeld's top picks in the U.S. are Nucor (NUE), Commercial Metals (CMC), Steel Dynamics (STLD), Reliance Steel (RS) and Cleveland-Cliffs (CLF).
FTNT Fortinet
$69.16

-1.34 (-1.90%)

01/18/19
OTRG
01/18/19
DOWNGRADE
OTRG
Mixed
Fortinet downgraded to Mixed from Positive at OTR Global
01/22/19
BMOC
01/22/19
DOWNGRADE
BMOC
Market Perform
Fortinet downgraded to Market Perform from Outperform at BMO Capital
01/22/19
BMOC
01/22/19
DOWNGRADE
Target $78
BMOC
Market Perform
Fortinet downgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital analyst Keith Bachman downgraded Fortinet to Market Perform and lowered his price target to $78 from $90. The analyst notes that he is not bearish on the stock, expecting the firewall market to remain healthy for several years given the changing throughput requirements, but sees the rating change as reflective of its more balanced risk-reward. Based on Fortinet's enterprise value to free cash flow multiple, Bachman contends that its valuation "reflects its revenue growth and FCF generating capabilities."
01/22/19
01/22/19
UPGRADE
Target $240

Outperform
Palo Alto Networks upgraded to Outperform at BMO Capital on valuation
As previously reported, BMO Capital analyst Keith Bachman upgraded Palo Alto Networks (PANW) to Outperform and raised his price target to $240 from $205. The analyst expects the company to benefit from the network firewall market remaining healthy over the next several years with market share gains. Bachman also sees Palo Alto Networks' product revenue sustaining the near 9% growth rate in FY20 thanks to its "new customer adds and expansion from existing customers against the backdrop of a healthy security spending environment". Based on his greater confidence in the company's ability to sustain subscriptions growth relative to Fortinet (FTNT), the analyst believes that Palo Alto Networks offers investors "meaningful upside potential".
CRSP Crispr Therapeutics
$32.07

-5.145 (-13.83%)

12/20/18
PIPR
12/20/18
NO CHANGE
Target $75
PIPR
Overweight
Piper Jaffray encouraged by enthusiasm for Crispr Therapeutics' CTX-001
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $75 price target, saying his interviews with hematologists indicate that the current standard-of-care hydroxyurea is poorly tolerated and offers "a huge opportunity" for emerging therapies. The analyst states that he is encouraged by "early enthusiasm based on the promise of CRISPR/Cas9 in SCD considering the company has yet to present any clinical data on CTX-001."
01/02/19
PIPR
01/02/19
NO CHANGE
Target $75
PIPR
Overweight
Crispr Therapeutics named a top pick for 2019 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff names Crispr Therapeutics a top pick for 2019 and reiterates an Overweight rating on the shares with a $75 price target. The stock closed the trading day up $1.30 to $29.87. Crispr is developing "revolutionary" CRISPR/Cas-9 technology as a new therapeutic modality with broad ranging applicability, Tenthoff tells investors in a research note. The Phase I/II studies of CTX-001 in transfusion-dependent beta thalassemia and sickle cell disease will report first-in-man data this year potentially curing patients of disease, adds the analyst.
01/22/19
SBSH
01/22/19
DOWNGRADE
SBSH
Sell
Crispr Therapeutics downgraded to Sell from Neutral at Citi
Citi analyst Yigal Nochomovitz downgraded Crispr Therapeutics to Sell.
01/22/19
SBSH
01/22/19
DOWNGRADE
Target $21
SBSH
Sell
Citi downgrades Crispr Therapeutics to Sell with $21 price target
Citi analyst Yigal Nochomovitz downgraded Crispr Therapeutics to Sell from Neutral and cut his price target for the shares to $21 from $28. Crispr's near-term valuation driver and lead program in related blood disorders "substantially lags" more advanced competitors, Nochomovitz tells investors in a research note. The analyst believes the company's CTX-001 is "at best equivalent" to more advanced competitors and "could have some important liabilities."
AMC AMC Entertainment
$13.98

-0.49 (-3.39%)

01/22/19
RILY
01/22/19
DOWNGRADE
Target $17
RILY
Neutral
AMC Entertainment downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Eric Wold downgraded AMC Entertainment to Neutral and lowered his price target for the shares to $17 from $29. The ramp of the company's subscription service Stubs A-List clouds its EBITDA visibility, Wold tells investors in a research note.
11/13/18
BRRR
11/13/18
NO CHANGE
BRRR
AMC seeing success with Stubs A-List, says Barrington
Barrington analyst James Goss reaffirmed an Outperform rating and $22 price target on AMC Entertainment, noting that the company's Stubs A-List program has been "significantly stronger than management's initial expectations, already surpassing 500,000, after hitting 400,000 just after the end of the third quarter." Goss added that the company now expects accretive profitability to occur a year ahead of schedule, and is increasing the program membership price in "select metro areas, generally to a level roughly equivalent to about 2.5 times the price of a single ticket in that market."
11/13/18
RILY
11/13/18
NO CHANGE
Target $29
RILY
Buy
AMC 16% pullback since Thursday an overreaction, says B. Riley FBR
B. Riley FBR analyst Eric Wold believes the 16% decline in AMC Entertainment since Thursday is an overreaction to the "no go" on the European initial public offering. The analyst sees an attractive set-up for AMC shares as the "impressive" 2019 film slate approaches and free cash flow begins to improve. He keeps a Buy rating on the stock with a $29 price target.
09/17/18
WEDB
09/17/18
NO CHANGE
Target $25
WEDB
Outperform
AMC could see multiple expansion with more consistent performance, says Wedbush
Wedbush analyst Michael Pachter reiterated an Outperform rating and $25 price target on AMC Entertainment, telling investors in a research note that another few quarters of consistent performance should result in multiple expansion so long as AMC remains committed to meaningfully paying down debt. Pachter expects AMC to trade at the high end of its historical 7-8.5x EV/EBITDA multiple range should it demonstrate consistent earnings power.

TODAY'S FREE FLY STORIES

YEXT

Yext

$23.00

0.33 (1.46%)

22:43
03/18/19
03/18
22:43
03/18/19
22:43
Syndicate
Yext 6.1M share Spot Secondary priced at $21.50 »

Goldman Sachs is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WU

Western Union

$18.17

-0.2 (-1.09%)

22:42
03/18/19
03/18
22:42
03/18/19
22:42
Hot Stocks
Western Union to partner with emerging-market moble network Thunes »

Western Union has teamed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$28.17

0.09 (0.32%)

22:40
03/18/19
03/18
22:40
03/18/19
22:40
Hot Stocks
Mylan conducts voluntary recall of Levoleucovorin Injection »

Mylan Institutional LLC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYHT

Shineco

$0.67

0.0003 (0.04%)

20:43
03/18/19
03/18
20:43
03/18/19
20:43
Recommendations
Shineco analyst commentary  »

Shineco establishing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$44.97

0.33 (0.74%)

20:31
03/18/19
03/18
20:31
03/18/19
20:31
Hot Stocks
Activision Blizzard unveils Call of Duty: Mobile edition »

Activision, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$372.10

-6.795 (-1.79%)

20:28
03/18/19
03/18
20:28
03/18/19
20:28
Hot Stocks
Boeing CEO says 'work progressing thoroughly' to understand cause for 737 crash »

In a letter, Boeing CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

GPX

GP Strategies

$12.57

-1.745 (-12.19%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Recommendations
GP Strategies analyst commentary at Barrington »

GP Strategies organic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

MIK

Michaels

$11.79

0.11 (0.94%)

, DSW

DSW

$25.30

-0.09 (-0.35%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MIK

Michaels

$11.79

0.11 (0.94%)

DSW

DSW

$25.30

-0.09 (-0.35%)

HDS

HD Supply

$43.09

0.09 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

, AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

20:19
03/18/19
03/18
20:19
03/18/19
20:19
Hot Stocks
Nvidia to partner with Amazon on bringing AI to connected devices »

NVIDIA (NVDA) announced a…

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

MEOH

Methanex

$57.22

1.68 (3.02%)

19:57
03/18/19
03/18
19:57
03/18/19
19:57
Hot Stocks
Methanex confirms M&G Investment letter, urges shareholders take no action »

Methanex confirms that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$43.09

0.09 (0.21%)

19:55
03/18/19
03/18
19:55
03/18/19
19:55
Earnings
HD Supply sees FY19 EPS $3.52-$3.81, consensus $3.64 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:53
03/18/19
03/18
19:53
03/18/19
19:53
Earnings
HD Supply sees Q1 EPS 75c-84c, consensus 85c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:52
03/18/19
03/18
19:52
03/18/19
19:52
Earnings
HD Supply reports Q4 adjusted EPS 70c, consensus 67c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

CASA

Casa Systems

$8.89

-0.06 (-0.67%)

19:47
03/18/19
03/18
19:47
03/18/19
19:47
Initiation
Casa Systems initiated at DA Davidson »

Casa Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$124.67

-0.41 (-0.33%)

19:46
03/18/19
03/18
19:46
03/18/19
19:46
Downgrade
Crown Castle rating change at Deutsche Bank »

Crown Castle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARPO

Aerpio Pharmaceuticals

$1.22

-2.915 (-70.58%)

19:39
03/18/19
03/18
19:39
03/18/19
19:39
Downgrade
Aerpio Pharmaceuticals rating change at Guggenheim »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

LIVX

LiveXLive Media

$6.30

0.19 (3.11%)

19:37
03/18/19
03/18
19:37
03/18/19
19:37
Initiation
LiveXLive Media initiated at Maxim »

LiveXLive Media initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 30

    Apr

  • 01

    May

AKBA

Akebia

$8.19

0.01 (0.12%)

19:31
03/18/19
03/18
19:31
03/18/19
19:31
Recommendations
Akebia analyst commentary at Piper Jaffray »

Akebia investors should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

VALE

Vale

$13.28

0.11 (0.84%)

19:18
03/18/19
03/18
19:18
03/18/19
19:18
Periodicals
Vale to resume activities at port after court injunction, Reuters reports »

Vale said Friday that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TROX

Tronox

$12.09

0.2 (1.68%)

19:00
03/18/19
03/18
19:00
03/18/19
19:00
Hot Stocks
Tronox to present National Titanium Dioxide deal to FTC »

Tronox confirmed that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYMTF

Hyundai Motor

$0.00

(0.00%)

, HYMLF

Hyundai Motor Co

$0.00

(0.00%)

18:58
03/18/19
03/18
18:58
03/18/19
18:58
Hot Stocks
Connecticut AG announces probe into Hyundai, Kia fires »

Connecticut Attorney…

HYMTF

Hyundai Motor

$0.00

(0.00%)

HYMLF

Hyundai Motor Co

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNH

Syneos Health

$47.42

0.49 (1.04%)

, TLRY

Tilray

$72.15

-0.38 (-0.52%)

18:54
03/18/19
03/18
18:54
03/18/19
18:54
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SYNH

Syneos Health

$47.42

0.49 (1.04%)

TLRY

Tilray

$72.15

-0.38 (-0.52%)

EOLS

Evolus

$23.80

-1.02 (-4.11%)

AMRS

Amyris

$3.83

-0.1 (-2.54%)

FOE

Ferro

$18.88

0.125 (0.67%)

REV

Revlon

$19.39

0.42 (2.21%)

AKBA

Akebia

$8.19

0.01 (0.12%)

TORC

ResTORbio

$8.97

0.27 (3.10%)

TACO

Del Taco

$10.60

0.47 (4.64%)

HQY

HealthEquity

$82.86

0.76 (0.93%)

CVTI

Covenant Transportation

$21.43

-0.4 (-1.83%)

YEXT

Yext

$23.00

0.33 (1.46%)

WAGE

WageWorks

$39.59

1.875 (4.97%)

TWO

Two Harbors

$14.26

0.07 (0.49%)

AGS

PlayAGS

$25.65

-0.89 (-3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

  • 16

    May

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

AAPL

Apple

$188.03

1.83 (0.98%)

18:52
03/18/19
03/18
18:52
03/18/19
18:52
Periodicals
Apple stops iOS 12.1.3 code signing after iOS 12.1.4 launch, AppleInsider says »

Apple has stopped signing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

$108.52

9.8 (9.93%)

, FIS

FIS

$108.14

-0.73 (-0.67%)

18:41
03/18/19
03/18
18:41
03/18/19
18:41
Downgrade
Worldpay, FIS rating change at BMO Capital »

Worldpay downgraded to…

WP

Worldpay

$108.52

9.8 (9.93%)

FIS

FIS

$108.14

-0.73 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ERIC

Ericsson

$9.56

-0.075 (-0.78%)

18:32
03/18/19
03/18
18:32
03/18/19
18:32
Hot Stocks
Ericsson selected by TDC to roll out commercial 5G in Denmark »

Ericsson has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.